AXON ENTERPRISE INC (AXON)

US05464C1018 - Common Stock

631.69  +16.01 (+2.6%)

Premarket: 631.69 0 (0%)

Fundamental Rating

7

AXON gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 64 industry peers in the Aerospace & Defense industry. AXON scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AXON is valued quite expensive, but it does show an excellent growth. These ratings would make AXON suitable for growth and quality investing!



7

1. Profitability

1.1 Basic Checks

AXON had positive earnings in the past year.
AXON had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AXON reported negative net income in multiple years.
AXON had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 10.79%, AXON belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
With an excellent Return On Equity value of 20.59%, AXON belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
AXON has a Return On Invested Capital (3.25%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 10.79%
ROE 20.59%
ROIC 3.25%
ROA(3y)2.22%
ROA(5y)1.33%
ROE(3y)5.56%
ROE(5y)3.33%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of AXON (18.01%) is better than 93.75% of its industry peers.
AXON's Profit Margin has improved in the last couple of years.
AXON has a Operating Margin (5.75%) which is in line with its industry peers.
AXON's Operating Margin has improved in the last couple of years.
AXON has a better Gross Margin (59.14%) than 92.19% of its industry peers.
In the last couple of years the Gross Margin of AXON has remained more or less at the same level.
Industry RankSector Rank
OM 5.75%
PM (TTM) 18.01%
GM 59.14%
OM growth 3YN/A
OM growth 5Y10.86%
PM growth 3YN/A
PM growth 5Y9.9%
GM growth 3Y-0.01%
GM growth 5Y-0.15%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXON is destroying value.
AXON has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AXON has more shares outstanding
The debt/assets ratio for AXON has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 16.60 indicates that AXON is not in any danger for bankruptcy at the moment.
AXON has a better Altman-Z score (16.60) than 96.88% of its industry peers.
AXON has a debt to FCF ratio of 3.09. This is a good value and a sign of high solvency as AXON would need 3.09 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.09, AXON belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
AXON has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
AXON's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. AXON outperforms 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.09
Altman-Z 16.6
ROIC/WACC0.33
WACC9.71%

2.3 Liquidity

A Current Ratio of 2.96 indicates that AXON has no problem at all paying its short term obligations.
The Current ratio of AXON (2.96) is better than 67.19% of its industry peers.
A Quick Ratio of 2.63 indicates that AXON has no problem at all paying its short term obligations.
AXON has a better Quick ratio (2.63) than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.63

9

3. Growth

3.1 Past

AXON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.61%, which is quite impressive.
AXON shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 45.65% yearly.
Looking at the last year, AXON shows a very strong growth in Revenue. The Revenue has grown by 63.57%.
AXON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.06% yearly.
EPS 1Y (TTM)32.61%
EPS 3Y32.14%
EPS 5Y45.65%
EPS Q2Q%42.16%
Revenue 1Y (TTM)63.57%
Revenue growth 3Y31.92%
Revenue growth 5Y30.06%
Sales Q2Q%31.59%

3.2 Future

AXON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.30% yearly.
AXON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.71% yearly.
EPS Next Y28.46%
EPS Next 2Y24.48%
EPS Next 3Y24.3%
EPS Next 5YN/A
Revenue Next Year33.73%
Revenue Next 2Y28.38%
Revenue Next 3Y25.71%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 128.39, AXON can be considered very expensive at the moment.
AXON's Price/Earnings is on the same level as the industry average.
AXON is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 98.71, which means the current valuation is very expensive for AXON.
AXON's Price/Forward Earnings ratio is in line with the industry average.
AXON is valuated expensively when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 128.39
Fwd PE 98.71

4.2 Price Multiples

AXON's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AXON is more expensive than 64.06% of the companies in the same industry.
AXON's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 218.81
EV/EBITDA 264.15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AXON does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of AXON may justify a higher PE ratio.
A more expensive valuation may be justified as AXON's earnings are expected to grow with 24.30% in the coming years.
PEG (NY)4.51
PEG (5Y)2.81
EPS Next 2Y24.48%
EPS Next 3Y24.3%

0

5. Dividend

5.1 Amount

No dividends for AXON!.
Industry RankSector Rank
Dividend Yield N/A

AXON ENTERPRISE INC

NASDAQ:AXON (12/20/2024, 8:00:01 PM)

Premarket: 631.69 0 (0%)

631.69

+16.01 (+2.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners81.14%
Inst Owner ChangeN/A
Ins Owners0.73%
Ins Owner Change-8.43%
Market Cap48.17B
Analysts84.55
Price Target564.17 (-10.69%)
Short Float %3.1%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.83%
Min EPS beat(2)15%
Max EPS beat(2)18.66%
EPS beat(4)4
Avg EPS beat(4)20.44%
Min EPS beat(4)15%
Max EPS beat(4)28.74%
EPS beat(8)8
Avg EPS beat(8)35.66%
EPS beat(12)12
Avg EPS beat(12)44.55%
EPS beat(16)16
Avg EPS beat(16)71.95%
Revenue beat(2)2
Avg Revenue beat(2)2.46%
Min Revenue beat(2)1.63%
Max Revenue beat(2)3.29%
Revenue beat(4)4
Avg Revenue beat(4)1.96%
Min Revenue beat(4)0.65%
Max Revenue beat(4)3.29%
Revenue beat(8)8
Avg Revenue beat(8)3.65%
Revenue beat(12)12
Avg Revenue beat(12)5.06%
Revenue beat(16)16
Avg Revenue beat(16)8.38%
PT rev (1m)45.27%
PT rev (3m)50.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.57%
EPS NY rev (1m)6.99%
EPS NY rev (3m)8.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.09%
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)2.17%
Valuation
Industry RankSector Rank
PE 128.39
Fwd PE 98.71
P/S 20.07
P/FCF 218.81
P/OCF 161.53
P/B 22.94
P/tB 28.17
EV/EBITDA 264.15
EPS(TTM)4.92
EY0.78%
EPS(NY)6.4
Fwd EY1.01%
FCF(TTM)2.89
FCFY0.46%
OCF(TTM)3.91
OCFY0.62%
SpS31.48
BVpS27.54
TBVpS22.42
PEG (NY)4.51
PEG (5Y)2.81
Profitability
Industry RankSector Rank
ROA 10.79%
ROE 20.59%
ROCE 4.34%
ROIC 3.25%
ROICexc 5.1%
ROICexgc 6.32%
OM 5.75%
PM (TTM) 18.01%
GM 59.14%
FCFM 9.17%
ROA(3y)2.22%
ROA(5y)1.33%
ROE(3y)5.56%
ROE(5y)3.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-3.88%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.69%
OM growth 3YN/A
OM growth 5Y10.86%
PM growth 3YN/A
PM growth 5Y9.9%
GM growth 3Y-0.01%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.09
Debt/EBITDA 3.8
Cap/Depr 191.32%
Cap/Sales 3.25%
Interest Coverage 250
Cash Conversion 166.79%
Profit Quality 50.92%
Current Ratio 2.96
Quick Ratio 2.63
Altman-Z 16.6
F-Score5
WACC9.71%
ROIC/WACC0.33
Cap/Depr(3y)227.92%
Cap/Depr(5y)282.35%
Cap/Sales(3y)4.8%
Cap/Sales(5y)5.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.61%
EPS 3Y32.14%
EPS 5Y45.65%
EPS Q2Q%42.16%
EPS Next Y28.46%
EPS Next 2Y24.48%
EPS Next 3Y24.3%
EPS Next 5YN/A
Revenue 1Y (TTM)63.57%
Revenue growth 3Y31.92%
Revenue growth 5Y30.06%
Sales Q2Q%31.59%
Revenue Next Year33.73%
Revenue Next 2Y28.38%
Revenue Next 3Y25.71%
Revenue Next 5YN/A
EBIT growth 1Y2.57%
EBIT growth 3YN/A
EBIT growth 5Y44.18%
EBIT Next Year94.3%
EBIT Next 3Y46.49%
EBIT Next 5YN/A
FCF growth 1Y272.22%
FCF growth 3YN/A
FCF growth 5Y19.84%
OCF growth 1Y154.49%
OCF growth 3Y70.06%
OCF growth 5Y24.26%